Advancements in AI-driven diagnostics could transform cardiology, enabling autonomous interpretation of up to 80% of cardiac imaging within a decade. David Ouyang, MD, discusses overcoming barriers to running…
This video discusses how significant excess bleeding halted a trial of idraparinux for stroke prevention in patients with atrial fibrillation. References and Resources The Amadeus Investigators. Comparison of…
The U.S. FDA issued an Early Communication regarding the agency’s ongoing review of Vytorin based on preliminary results from a recently completed study. References and Resources FDA Issues…
A meta analysis has reported that statin use among patients with heart failure was associated with a decrease in relative risk of death. The researchers conclude it is…
John D. Pigott, MD, MHA, Professor of Clinical Surgery, Tulane University School of Medicine, discusses the MiniMaze procedure in atrial fibrillation. References and Resources Ruchat P, Dang L,…
Thomas W. Young, MD, Pediatric Cardiologist, Ochner Children’s Health Center, New Orleans, Louisiana, discusses the updated guidelines for endocarditis prophylaxis. References and Resources AHA Antibiotic Prophylactic Regimens Recommended…
Victor Kim, MD, Assistant Professor of Medicine, Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses sleep disorders. References and Resources Taub LF, Redeker NS. Sleep…
Symptoms of acute coronary syndrome in women often differ from those in men, which may lead to misdiagnosis, according to a review reported in the Archives of Internal…
A joint meeting of the Nonprescription Drugs Advisory Committee and the Endocrinologic Drugs Advisory Committee voted 10-2, with one abstention, against recommending OTC use of lovastatin 20 mg…
This update highlights changes to the prescribing information for Avandia including a new boxed warning about the potential increased risk of myocardial ischemia. References and Resources FDA adds…
The FDA announced that Trasylol increases risk of death, and therefore a marketing suspension has occurred. References and Resources FDA Requests Marketing Suspension of Trasylol Click Here to…
